Patient considerations in the management of chronic constipation: focus on prucalopride

References

• BharuchaAEPembertonJHLockeGRAmerican Gastroenterological Association technical review on constipationGastroenterology2013144121823823261065
   PubMed Web of Science ®Google Scholar
• MearinFLacyBEChangLBowel DisordersGastroenterology2016150613931407
   Web of Science ®Google Scholar
• HigginsPDJohansonJFEpidemiology of constipation in North America: a systematic reviewAm J Gastroenterol200499475075915089911
   PubMed Web of Science ®Google Scholar
• MugieSMBenningaMADi LorenzoCEpidemiology of constipation in children and adults: a systematic reviewBest Pract Res Clin Gastroenterol201125131821382575
   PubMed Web of Science ®Google Scholar
• ChoungRSLockeGRSchleckCDZinsmeisterARTalleyNJCumulative incidence of chronic constipation: a population-based study 1988–2003Aliment Pharmacol Ther20072611–121521152817919271
   PubMed Web of Science ®Google Scholar
• WaldAScarpignatoCMueller-LissnerSA multinational survey of prevalence and patterns of laxative use among adults with self-defined constipationAliment Pharmacol Ther200828791793018644012
   PubMed Web of Science ®Google Scholar
• NeriLBasiliscoGCorazziariEConstipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipationUnited European Gastroenterol J201422138147
   Web of Science ®Google Scholar
• BelseyJGreenfieldSCandyDGeraintMSystematic review: impact of constipation on quality of life in adults and childrenAliment Pharmacol Ther201031993894920180788
   PubMed Web of Science ®Google Scholar
• JohansonJFKralsteinJChronic constipation: a survey of the patient perspectiveAliment Pharmacol Ther200725559960817305761
   PubMed Web of Science ®Google Scholar
• IrvineEJFerrazziSParePThompsonWGRanceLHealth-related quality of life in functional GI disorders: focus on constipation and resource utilizationAm J Gastroenterol20029781986199312190165
   PubMed Web of Science ®Google Scholar
• ShahNDChitkaraDKLockeGRMeekPDTalleyNJAmbulatory care for constipation in the United States, 1993–2004Am J Gastroenterol200810331746175318557708
   PubMed Web of Science ®Google Scholar
• FaigelDOA clinical approach to constipationClin Cornerstone200244112112739323
   PubMedGoogle Scholar
• SommersTCorbanCSenguptaNEmergency department burden of constipation in the United States from 2006 to 2011Am J Gastroenterol2015110457257925803399
   PubMed Web of Science ®Google Scholar
• BharuchaAEWaldAEnckPRaoSFunctional anorectal disordersGastroenterology200613051510151816678564
   PubMed Web of Science ®Google Scholar
• ChiarioniGSalandiniLWhiteheadWEBiofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipationGastroenterology20051291869716012938
   PubMed Web of Science ®Google Scholar
• ChiarioniGWhiteheadWEPezzaVMorelliABassottiGBiofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergiaGastroenterology2006130365766416530506
   PubMed Web of Science ®Google Scholar
• RaoSSSeatonKMillerMRandomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecationClin Gastroenterol Hepatol20075333133817368232
   PubMed Web of Science ®Google Scholar
• HeymenSScarlettYJonesKRingelYDrossmanDWhiteheadWERandomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipationDis Colon Rectum200750442844117294322
   PubMed Web of Science ®Google Scholar
• RaviKBharuchaAECamilleriMRhotenDBakkenTZinsmeisterARPhenotypic variation of colonic motor functions in chronic constipationGastroenterology20101381899719660461
   PubMed Web of Science ®Google Scholar
• CamilleriMBharuchaAEdi LorenzoCAmerican Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practiceNeurogastroenterol Motil200820121269128219019032
   PubMed Web of Science ®Google Scholar
• Vazquez RoqueMBourasEPEpidemiology and management of chronic constipation in elderly patientsClin Interv Aging20151091993026082622
   PubMed Web of Science ®Google Scholar
• JiangCXuQWenXSunHCurrent developments in pharmacological therapeutics for chronic constipationActa Pharm Sin B20155430030926579459
   PubMed Web of Science ®Google Scholar
• WaldAConstipation: advances in diagnosis and treatmentJAMA2016315218519126757467
   PubMed Web of Science ®Google Scholar
• De MaeyerJHLefebvreRASchuurkesJA5-HT4 receptor agonists: similar but not the sameNeurogastroenterol Motil20082029911218199093
   PubMed Web of Science ®Google Scholar
• PrinsNHShankleyNPWelshNJAn improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscleBr J Pharmacol200012981601160810780964
   PubMed Web of Science ®Google Scholar
• HegdeSSEglenRMPeripheral 5-HT4 receptorsFASEB J19961012139814078903510
   PubMed Web of Science ®Google Scholar
• BriejerMRAkkermansLMSchuurkesJAGastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motilityPharmacol Rev19954746316518746557
   PubMed Web of Science ®Google Scholar
• MohammadSZhouZGongQJanuaryCTBlockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisaprideAm J Physiol19972735 pt 2H2534H25389374794
   PubMedGoogle Scholar
• SmithJABeattieDTMarquessDShawJPVickeryRGHumphreyPPThe in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activityNaunyn Schmiedebergs Arch Pharmacol2008378112513718415081
   PubMed Web of Science ®Google Scholar
• CamilleriMVazquez-RoqueMIBurtonDPharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humansNeurogastroenterol Motil2007191303817187586
   PubMed Web of Science ®Google Scholar
• MendzelevskiBAusmaJChanterDOAssessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT studyBr J Clin Pharmacol201273220320921848574
   PubMed Web of Science ®Google Scholar
• ShinACamilleriMKolarGErwinPWestCPMuradMHSystematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipationAliment Pharmacol Ther201439323925324308797
   PubMed Web of Science ®Google Scholar
• FramptonJEPrucaloprideDrugs200969172463247619911858
   PubMed Web of Science ®Google Scholar
• CamilleriMDeiterenAPrucalopride for constipationExpert Opin Pharmacother201011345146120102308
   PubMed Web of Science ®Google Scholar
• LeelakusolvongSKeMZouDFactors predictive of treatment-emergent adverse events of prucalopride: an integrated analysis of four randomized, double-blind, placebo-controlled trialsGut Liver20159220821325534573
   PubMed Web of Science ®Google Scholar
• BriejerMRBosmansJPVan DaelePThe in vitro pharmacological profile of prucalopride, a novel enterokinetic compoundEur J Pharmacol20014231718311438309
   PubMed Web of Science ®Google Scholar
• BriejerMRPrinsNHSchuurkesJAEffects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogsNeurogastroenterol Motil200113546547211696108
   PubMed Web of Science ®Google Scholar
• MisraSRandomized double blind placebo control studies, the “Gold Standard” in intervention based studiesIndian J Sex Transm Dis201233213113423188942
   PubMedGoogle Scholar
• BourasEPCamilleriMBurtonDDMcKinzieSSelective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humansGut199944568268610205205
   PubMed Web of Science ®Google Scholar
• PoenACFelt-BersmaRJVan DongenPAMeuwissenSGEffect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteersAliment Pharmacol Ther199913111493149710571606
   PubMed Web of Science ®Google Scholar
• EmmanuelAVKammMARoyAJAntonelliKEffect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteersGut19984245115169616313
   PubMed Web of Science ®Google Scholar
• EmmanuelAVRoyAJNichollsTJKammMAPrucalopride, a systemic enterokinetic, for the treatment of constipationAliment Pharmacol Ther20021671347135612144586
   PubMed Web of Science ®Google Scholar
• SlootsCEPoenACKerstensREffects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipationAliment Pharmacol Ther200216475976711929394
   PubMed Web of Science ®Google Scholar
• BourasEPCamilleriMBurtonDDThomfordeGMcKinzieSZinsmeisterARPrucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorderGastroenterology2001120235436011159875
   PubMed Web of Science ®Google Scholar
• CoremansGKerstensRDe PauwMStevensMPrucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trialDigestion2003671–2828912743445
   PubMed Web of Science ®Google Scholar
• EmmanuelACoolsMVandeplasscheLKerstensRPrucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysisAm J Gastroenterol2014109688789424732867
   PubMed Web of Science ®Google Scholar
• CamilleriMKerstensRRykxAVandeplasscheLA placebo-controlled trial of prucalopride for severe chronic constipationN Engl J Med2008358222344235418509121
   PubMed Web of Science ®Google Scholar
• QuigleyEMVandeplasscheLKerstensRAusmaJClinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled studyAliment Pharmacol Ther200929331532819035970
   PubMed Web of Science ®Google Scholar
• TackJvan OutryveMBeyensGKerstensRVandeplasscheLPrucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxativesGut200958335736518987031
   PubMed Web of Science ®Google Scholar
• KeMZouDYuanYPrucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled studyNeurogastroenterol Motil20122411999e54122882724
   PubMed Web of Science ®Google Scholar
• YiannakouYPiessevauxHBouchouchaMA randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipationAm J Gastroenterol2015110574174825869393
   PubMed Web of Science ®Google Scholar
• CamilleriMVan OutryveMJBeyensGKerstensRRobinsonPVandeplasscheLClinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation – follow-up of patients from the pivotal studiesAliment Pharmacol Ther20103291113112321039673
   PubMed Web of Science ®Google Scholar
• Müller-LissnerSRykxAKerstensRVandeplasscheLA double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipationNeurogastroenterol Motil2010229991998e25520529205
   PubMed Web of Science ®Google Scholar
• CincaRCheraDGrussHJHalphenMRandomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation – a comparison in a controlled environmentAliment Pharmacol Ther201337987688623480216
   PubMed Web of Science ®Google Scholar
• NHS Regional Drug and Therapeutics CentreCost Comparison Charts. Oct 2015NewcastleNHS Regional Drug and Therapeutics Centre2015
   Google Scholar
• LiuBWangYWuJEffect of electroacupuncture versus prucalopride for severe chronic constipation: protocol of a multi-centre, non-inferiority, randomised controlled trialBMC Complement Altern Med20141426025055821
   PubMed Web of Science ®Google Scholar
• HerzMJKahanEZalevskiSAframianRKuznitzDReichmanSConstipation: a different entity for patients and doctorsFam Pract19961321561598732327
   PubMed Web of Science ®Google Scholar
• FrankLKleinmanLFarupCTaylorLMinerPJrPsychometric validation of a constipation symptom assessment questionnaireScand J Gastroenterol199934987087710522604
   PubMed Web of Science ®Google Scholar
• NeriLConwayPMBasiliscoGLaxative Inadequate Relief Survey (LIRS) GroupConfirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipationQual Life Res20152471597160525522976
   PubMed Web of Science ®Google Scholar
• TackJStanghelliniVDuboisDJosephAVandeplasscheLKerstensREffect of prucalopride on symptoms of chronic constipationNeurogastroenterol Motil2014261212724106924
   PubMed Web of Science ®Google Scholar
• DuboisDGiletHViala-DantenMTackJPsychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipationNeurogastroenterol Motil2010222e54e6319761492
   PubMed Web of Science ®Google Scholar
• MarquisPDe La LogeCDuboisDMcDermottAChassanyODevelopment and validation of the Patient Assessment of Constipation Quality of Life questionnaireScand J Gastroenterol200540554055116036506
   PubMed Web of Science ®Google Scholar
• TackJCamilleriMDuboisDVandeplasscheLJosephAKerstensRAssociation between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucaloprideNeurogastroenterol Motil201527339740525581251
   PubMed Web of Science ®Google Scholar
• CamilleriMBeyensGKerstensRRobinsonPVandeplasscheLSafety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled studyNeurogastroenterol Motil200921121256e11719751247
   PubMed Web of Science ®Google Scholar
• PiessevauxHCorazziariEReyEA randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucaloprideNeurogastroenterol Motil201527680581525808103
   PubMed Web of Science ®Google Scholar
• CamilleriMPiessevauxHYiannakouYEfficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trialsDig Dis Sci Epub201647
   Web of Science ®Google Scholar